Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia

Cell Death and Disease

Volumn 1, Issue 12, 2010, Pages

  Wemeau, M ^a,b,c,d   Kepp, O ^b,d,e   Tesniere A ^b,d,e   Panaretakis, T ^b,d,e,f   Flament, C ^a,b,c   De Botton, S ^b   Zitvogel, L ^a,b,c,d   Kroemer, G ^b,e,g,h,i,j   Chaput, N ^a,b,c  

^a University Paris XI   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Centre d'Investigation Clinique Biothé Rapie 507   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Institut Gustave Roussy   (France)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Metabolomics Platform   (France)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

Acute myeloid leukemia; Anthracyclines; Calreticulin exposure; T cells immunity

Indexed keywords

ANTHRACYCLINE; CALRETICULIN; GAMMA INTERFERON; ANTINEOPLASTIC AGENT; INITIATION FACTOR 2;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; HUMAN; IN VIVO STUDY; LEUKEMIA CELL; MOUSE; MYELOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; ADULT; AGED; COHORT ANALYSIS; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHAGOCYTOSIS; PHOSPHORYLATION; PHYSIOLOGY; SURVIVAL; T LYMPHOCYTE;

MUS;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CALRETICULIN; COHORT STUDIES; DENDRITIC CELLS; EUKARYOTIC INITIATION FACTOR-2; FEMALE; HUMANS; IMMUNITY, CELLULAR; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PHAGOCYTOSIS; PHOSPHORYLATION; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 79952397249     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.82     Document Type: Article

References (40)

1. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296-306. (Pubitemid 40516155)
2. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N et al. Caspasedependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202: 1691-1701. (Pubitemid 41815875)
3. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54-61. (Pubitemid 46067386)
4. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15: 1170-1178.
5. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-1059. (Pubitemid 47517504)
6. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007; 67: 10631-10634. (Pubitemid 350145884)
7. Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M et al. The cotranslocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008; 15: 1499-1509.
8. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. Embo J 2009; 28: 578-590.
9. Kapp M, Stevanovic S, Fick K, Tan SM, Loeffler J, Opitz A et al. CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplant 2009; 43: 399-410.
10. Robin M, Andreu-Gallien J, Schlageter MH, Bengoufa D, Guillemot I, Pokorna K et al. Frequent antibody production against RARalpha in both APL mice and patients. Blood 2006; 108: 1972-1974. (Pubitemid 44395008)
11. Montagna D, Maccario R, Locatelli F, Montini E, Pagani S, Bonetti F et al. Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood 2006; 108: 3843-3850. (Pubitemid 44864567)
12. Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A et al. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res 2009; 15: 3325-3332.
13. Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J Cell Biol 1996; 135: 533-544. (Pubitemid 26359345)
14. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996; 274: 795-798. (Pubitemid 26398263)
15. Miyashita M, Ohnishi H, Okazawa H, Tomonaga H, Hayashi A, Fujimoto TT et al. Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42. Mol Biol Cell 2004; 15: 3950-3963. (Pubitemid 38989727)
16. Reinhold MI, Lindberg FP, Kersh GJ, Allen PM, Brown EJ. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med 1997; 185: 1-11. (Pubitemid 27039436)
17. Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem 1999; 274: 559-562.
18. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science 2000; 288: 2051-2054. (Pubitemid 30397687)
19. Blazar BR, Lindberg FP, Ingulli E, Panoskaltsis-Mortari A, Oldenborg PA, Iizuka K et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med 2001; 194: 541-549. (Pubitemid 32835048)
20. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009; 138: 271-285.
21. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs Jr KD et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009; 138: 286-299.
22. Choudhury BA, Liang JC, Thomas EK, Flores-Romo L, Xie QS, Agusala K et al. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 1999; 93: 780-786. (Pubitemid 29067842)
23. Kohler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B et al. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 2000; 18: 139-147. (Pubitemid 30176808)
24. Li L, Reinhardt P, Schmitt A, Barth TF, Greiner J, Ringhoffer M et al. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens. Cancer Immunol Immunother 2005; 54: 685-693. (Pubitemid 40884165)
25. Cignetti A, Vallario A, Roato I, Circosta P, Allione B, Casorzo L et al. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J Immunol 2004; 173: 2855-2865. (Pubitemid 39063148)
26. van den Berg TK, van der Schoot CE. Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation. Trends Immunol 2008; 29: 203-206.
27. Adams S, van der Laan LJ, Vernon-Wilson E, Renardel de Lavalette C, Dopp EA, Dijkstra CD et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol 1998; 161: 1853-1859. (Pubitemid 28387606)
28. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006; 6: 457-464.
29. van Beek EM, Cochrane F, Barclay AN, van den Berg TK. Signal regulatory proteins in the immune system. J Immunol 2005; 175: 7781-7787. (Pubitemid 41798335)
30. Okazawa H, Motegi S, Ohyama N, Ohnishi H, Tomizawa T, Kaneko Y et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol 2005; 174: 2004-2011. (Pubitemid 40223942)
31. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through transactivation of LRP on the phagocyte. Cell 2005; 123: 321-334. (Pubitemid 41457220)
32. Tufi R, Panaretakis T, Bianchi K, Criollo A, Fazi B, Di Sano F et al. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ 2008; 15: 274-282.
33. Coquerelle C, Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev 2010; 234: 317-334.
34. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146. (Pubitemid 37328691)
35. Schakel K, von Kietzell M, Hansel A, Ebling A, Schulze L, Haase M et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 2006; 24: 767-777. (Pubitemid 43884896)
36. Wehner R, Lobel B, Bornhauser M, Schakel K, Cartellieri M, Bachmann M et al. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells. Int J Cancer 2009; 124: 358-366.
37. Schakel K, Mayer E, Federle C, Schmitz M, Riethmuller G, Rieber EP. A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol 1998; 28: 4084-4093. (Pubitemid 28558638)
38. Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207: 1261-1271.
39. Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J et al. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Int J Oncol 2006; 28: 855-861.
40. Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 2005; 24: 7503-7513. (Pubitemid 41638026)